FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns prediction of essential hypertension. That is ensured by isolating DNA from peripheral venous blood of patients, followed by amplification of polymorphous variants CACNA1C G2236129A (rs1006737), CACNA1C G2585485A (rs112532048), CACNA1H G1134967A (rs11865472), CACNA1G G50615794A (rs11079919), CACNB2 C18539252T (rs143326262), RYR2 G237115840T (rs2490389). Depending on the revealed combinations of genotypes, the development of essential hypertension is predicted.
EFFECT: invention enables predicting the development of preclinical hypertension, which, accordingly, enables timely prevention of the disease.
1 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF DEVELOPING ESSENTIAL HYPERTENSION | 2017 |
|
RU2661604C1 |
| METHOD FOR PREDICTION OF RISK OF ESSENTIAL HYPERTENSION DEVELOPMENT BASED ON MATRIX METAL PROTEINASE GENES COMBINATIONS | 2016 |
|
RU2624480C1 |
| METHOD FOR PREDICTION OF MEN'S RISK OF ESSENTIAL HYPERTENSION ASSOCIATED WITH OBESITY | 2018 |
|
RU2693469C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA | 2023 |
|
RU2809798C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING HYPERTENSION BASED ON DATA ON INTERGENIC INTERACTIONS | 2023 |
|
RU2809911C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ESSENTIAL HYPERTENSION IN WOMEN | 2011 |
|
RU2458144C1 |
| METHOD FOR ASSESSING THE RISK OF PREMATURE REDUCTION OF OVARIAN RESERVE | 2022 |
|
RU2791586C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING HYPERTENSION IN MEN BASED ON RESULTS OF GENETIC TESTING | 2023 |
|
RU2809912C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF HYPERTENSIVE DISEASE FACTORED IN GENETIC AND ENVIRONMENTAL FACTORS | 2018 |
|
RU2678441C1 |
| METHOD FOR PREDICTION OF ESSENTIAL ARTERIAL HYPERTENSION IN FEMALES WITH HYPERTENSIVE DISORDERS ACCOMPANYING PREGNANCY | 2012 |
|
RU2480762C1 |
